GAD Clinical Trials in Bron
2 recruitingBron, France
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
Hoffmann-La Roche152 enrolled82 locationsNCT05271409
Recruiting
Medium-term Effects of Treatments in Autoimmune Encephalitis
GFAPNMDAR Autoimmune EncephalitisLGI1 Antibody Associated Encephalitis+3 more
Hospices Civils de Lyon200 enrolled1 locationNCT07133113